Today: 30 April 2026
Browse Category

Stock Market 31 December 2025

Intel stock price today: INTC rises in premarket as Nvidia’s $5 billion stake takes focus

Intel stock price today: INTC rises in premarket as Nvidia’s $5 billion stake takes focus

Intel shares rose 1.6% to $37.90 in premarket trading Wednesday after a filing confirmed it sold $5 billion in stock to Nvidia at $23.28 per share in a private placement. The deal, completed December 26, gives Nvidia about 4% of Intel. Intel closed Tuesday at $37.30, up 1.7%. Investors await Intel’s late-January earnings and updates on its partnership with Nvidia.
31 December 2025
····
Datavault AI (DVLT) stock today: shares slide in premarket as warrant-dividend plan sharpens focus on Jan. 7 record date

Datavault AI (DVLT) stock today: shares slide in premarket as warrant-dividend plan sharpens focus on Jan. 7 record date

Datavault AI shares fell about 20% to $0.52 in early premarket trading Wednesday. The company announced a special dividend of stock warrants and a crypto token, both with a Jan. 7 record date. Recent filings showed insider share sales for tax withholding. Datavault also plans to exhibit at CES 2026 and was added to the S&P Semiconductors Select Industry Index.
31 December 2025
·
Robinhood stock slips in premarket after December trading snapshot; Barclays flags crypto softness

Robinhood stock slips in premarket after December trading snapshot; Barclays flags crypto softness

Robinhood shares fell about 0.6% premarket Wednesday after the company reported $170 billion in equity trading and $19 billion in crypto volume from Dec. 1-28. The stock closed at $115.45 Tuesday and was last indicated around $114.80. Needham cut its price target to $135. Barclays said weaker crypto trading may weigh on Q4 revenue, partly offset by strong options and Bitstamp activity.
31 December 2025
··
Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next

Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next

Rivian shares fell 0.9% to $19.42 in premarket trading Wednesday after a 5.2% drop the previous session. CEO R.J. Scaringe sold 17,450 shares on Dec. 23 under a pre-arranged plan, according to a regulatory filing. Investors are awaiting Rivian’s quarterly production and delivery update and Tesla’s delivery report for signs of electric-vehicle demand.
31 December 2025
···
XPeng stock today: XPEV slides in premarket as China trade-in subsidies and new G7 REEV grab attention

XPeng stock today: XPEV slides in premarket as China trade-in subsidies and new G7 REEV grab attention

XPeng shares dropped 4.2% to $20.38 in premarket trading Wednesday, reversing a 3.8% gain from the previous session. The move followed China’s announcement of 62.5 billion yuan in 2026 trade-in subsidies for consumer goods, including new-energy vehicles. CEO He Xiaopeng detailed plans for a range-extended G7 model set to debut in early 2026.
31 December 2025
····
TSMC stock today: Taiwan Semi slips premarket on Nvidia H200 supply talks and a 2nm production update

TSMC stock today: Taiwan Semi slips premarket on Nvidia H200 supply talks and a 2nm production update

TSMC’s U.S.-listed shares fell 0.4% to $299.58 in premarket trading after Reuters reported Nvidia asked the chipmaker to expand H200 AI chip production for Chinese buyers. Chinese firms have ordered over 2 million H200 chips for 2026, with pricing near $27,000 each. TSMC also said it began volume production of its 2nm chips in Q4.
31 December 2025
····
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers Health shares fell 0.5% to $32.87 in premarket trading Wednesday after closing down 3.1% the previous session. The move follows price cuts by Novo Nordisk and Eli Lilly on obesity drugs in China, raising questions about future margins and demand for GLP-1 therapies. Hims recently launched its weight-loss membership in the UK, offering access to Wegovy and Mounjaro.
31 December 2025
····
Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Oriental Culture Holding shares rose 1.8% to $0.104 in premarket trading Wednesday after a 23% jump Tuesday, with 342 million shares traded. The company disclosed recent share sales under a $200 million at-the-market program and shareholder approval for a possible reverse split. Traders are watching dilution risk and compliance steps as the stock’s 52-week range spans $0.07 to $19.29.
31 December 2025
·
iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing

iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing

iSpecimen Inc shares fell about 15% to $0.30 premarket after announcing a $5.5 million private placement of Series C convertible preferred stock. The preferred converts to common shares at a 15% discount to the prior day’s close, raising dilution concerns. The company remains below Nasdaq’s $1 minimum bid, with a compliance deadline of May 2026. Financing is expected to close Wednesday.
31 December 2025
·
Direct Digital (DRCT) stock jumps in premarket as SEC filing spotlights Nasdaq listing crunch

Direct Digital (DRCT) stock jumps in premarket as SEC filing spotlights Nasdaq listing crunch

Direct Digital Holdings shares jumped about 35% in premarket trading after the company disclosed its special shareholder meeting was adjourned for lack of quorum and rescheduled to Dec. 30. Investors are watching a pending vote on a reverse stock split and share-issuance proposals needed to meet Nasdaq’s $1 minimum bid requirement. The company faces a Jan. 30, 2026 deadline to regain compliance or risk delisting.
31 December 2025
··
1 … 752 753 754 755 756 … 1,402

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop